SAP102 Protein — Synapse-Associated Protein 102

Migration, Crosslink

📖

SAP102 Protein — Synapse-Associated Protein 102

active

wiki page Created: 2026-04-02T07:19:13 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-proteins-sap102-protein

📖 Wiki Page

protein1964 wordssynced 2026-04-02

SAP102 Protein — Synapse-Associated Protein 102

Introduction

SAP102 (Synapse-Associated Protein 102), also known as DLG3 (Discs Large Homolog 3), is a 102 kDa postsynaptic scaffolding protein belonging to the Membrane-Associated Guanylate Kinase (MAGUK) family. SAP102 plays critical roles in organizing the postsynaptic density, anchoring neurotransmitter receptors (particularly [NMDA receptors](/entities/nmda-receptor)), and coordinating synaptic signaling cascades essential for learning, memory, and cognitive function. The protein is particularly important during brain development and is highly expressed in the [hippocampus](/brain-regions/hippocampus) and [cerebral cortex](/brain-regions/cortex)[@dlgsap2020].

...

SAP102 Protein — Synapse-Associated Protein 102

Introduction

SAP102 (Synapse-Associated Protein 102), also known as DLG3 (Discs Large Homolog 3), is a 102 kDa postsynaptic scaffolding protein belonging to the Membrane-Associated Guanylate Kinase (MAGUK) family. SAP102 plays critical roles in organizing the postsynaptic density, anchoring neurotransmitter receptors (particularly [NMDA receptors](/entities/nmda-receptor)), and coordinating synaptic signaling cascades essential for learning, memory, and cognitive function. The protein is particularly important during brain development and is highly expressed in the [hippocampus](/brain-regions/hippocampus) and [cerebral cortex](/brain-regions/cortex)[@dlgsap2020].

<div class="infobox infobox-protein">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">Synapse-Associated Protein 102</th></tr>
<tr><td><strong>Protein Name</strong></td><td>SAP102, DLG3</td></tr>
<tr><td><strong>Gene</strong></td><td>[DLG3](/genes/dlg3)</td></tr>
<tr><td><strong>UniProt ID</strong></td><td>[Q92796](https://www.uniprot.org/uniprot/Q92796)</td></tr>
<tr><td><strong>PDB Structures</strong></td><td>2FY7, 3UAT</td></tr>
<tr><td><strong>Molecular Weight</strong></td><td>~102 kDa</td></tr>
<tr><td><strong>Protein Length</strong></td><td>904 amino acids</td></tr>
<tr><td><strong>Subcellular Localization</strong></td><td>Postsynaptic density, postsynaptic membrane</td></tr>
<tr><td><strong>Protein Family</strong></td><td>MAGUK family</td></tr>
<tr><td><strong>Chromosomal Location</strong></td><td>Xq13.1</td></tr>
</table>
</div>

Overview

SAP102 is a member of the MAGUK family of synaptic scaffold proteins that includes [PSD-95](/proteins/psd95-protein) (DLG4), [SAP97](/proteins/sap97-protein) (DLG1), and [PSD-93](/proteins/psd93-protein) (DLG2). Unlike its relatives, SAP102 is prominently expressed during early development and in specific brain regions including the hippocampus and cortex. The protein contains three PDZ domains, an SH3 domain, and a guanylate kinase (GK) domain, enabling it to interact with numerous synaptic proteins including NMDA receptors, AMPA receptors, and various signaling molecules[@psd95structure].

The DLG3 gene is located on the X chromosome, making SAP102 subject to X-linked inheritance patterns. Mutations in DLG3 cause X-linked intellectual disability, and variants have been associated with schizophrenia and autism. In the context of neurodegeneration, SAP102 interactions with [amyloid-beta](/proteins/amyloid-beta) and [tau](/proteins/tau) pathology are areas of active investigation[@dlg2023].

Structure

Domain Architecture

SAP102 contains multiple protein interaction domains that enable its scaffolding function:

Mermaid diagram (expand to render)

| Domain | Position | Function |
|--------|----------|----------|
| PDZ1 | 1-90 | Primary NMDA receptor binding (GluN2A, GluN2B C-termini) |
| PDZ2 | 91-180 | Kv1.x potassium channel binding, additional interactions |
| PDZ3 | 181-270 | Protein interactions, some redundancy with PDZ1/2 |
| SH3 | 320-380 | Proline-rich protein interactions |
| GK | 450-800 | GKAP binding, postsynaptic density organization |

Structural Features

The MAGUK family proteins share a characteristic architecture[@maguk2022]:

PDZ domains: ~90 amino acid modules that recognize specific C-terminal sequences (X-S/T-X-Φ, where Φ = hydrophobic). PDZ1 of SAP102 has high affinity for the C-terminal motif of NMDA receptor subunits.

SH3 domain: Recognizes proline-rich sequences (PXXP motifs) in partner proteins.

GK domain: Homologous to guanylate kinase but typically lacks catalytic activity. Instead, it serves as a protein-protein interaction domain, particularly with GKAP (GK-associated proteins).

N-terminal variable region: Contains targeting signals for synaptic localization.

Comparison with Other MAGUK Proteins

| Protein | Gene | Expression Pattern | Primary Interactions |
|---------|------|-------------------|---------------------|
| SAP102 (DLG3) | DLG3 | Early development, hippocampus/cortex | NMDA receptors, Kv channels |
| PSD-95 (DLG4) | DLG4 | Adult brain, all regions | NMDA, AMPA, Kv channels |
| SAP97 (DLG1) | DLG1 | Ubiquitous, development | NMDA, AMPA, tight junctions |
| PSD-93 (DLG2) | DLG2 | Brain, early development | NMDA, charybdotoxin |

Normal Function

Postsynaptic Scaffolding

SAP102 functions as a critical postsynaptic scaffold that organizes the postsynaptic density (PSD)[@synapseassembly]:

Receptor anchoring: SAP102 directly binds to the C-terminal tails of NMDA receptor subunits (GluN2A, GluN2B), anchoring them to the postsynaptic membrane.

Signaling complex assembly: SAP102 recruits signaling molecules including neuronal nitric oxide synthase (nNOS)[@noscoupling], PI3K, and other enzymes to the postsynaptic site.

Cytoskeletal organization: Through interactions with actin-binding proteins, SAP102 links the receptor-signaling complex to the cytoskeleton[@actincytoskeleton].

Synapse assembly: During development, SAP102 is essential for proper formation of excitatory synapses.

NMDA Receptor Regulation

NMDA receptors are critical for synaptic plasticity, learning, and memory[@nmdaframework]. SAP102 regulates NMDA receptors through multiple mechanisms:

Direct binding: PDZ domains of SAP102 bind to the C-terminal PDZ-binding motif of GluN2A/B subunits

Clustering: SAP102 oligomerization helps cluster NMDA receptors at synaptic sites

Trafficking: SAP102 participates in forward trafficking of NMDA receptors from the endoplasmic reticulum to the synapse

Signaling: SAP102 couples NMDA receptor activation to downstream signaling pathways including nNOS activation

Mermaid diagram (expand to render)

Synaptic Plasticity

SAP102 is essential for both long-term potentiation (LTP) and long-term depression (LTD)[@synapseplasticity]:

LTP induction: NMDA receptor activation triggers Ca²⁺ influx, which activates CaMKII and other plasticity-related kinases. SAP102 helps organize this signaling cascade.

LTD induction: SAP102 also participates in LTD mechanisms involving AMPA receptor internalization.

Homeostatic plasticity: SAP102 contributes to synaptic scaling and other homeostatic responses.

Interaction Partners

SAP102 interacts with numerous synaptic proteins:

| Partner | Interaction Domain | Functional Significance |
|---------|-------------------|------------------------|
| GluN2A/B (NMDA subunits) | PDZ1/2 | Receptor anchoring |
| Kv1.x channels | PDZ2 | Membrane potential regulation |
| nNOS | PDZ domain | NO signaling |
| GKAP | GK domain | PSD organization |
| AKAP79 | Multiple | PKA anchoring |
| GSK3β | Direct binding | Tau phosphorylation regulation |

Role in Disease

X-Linked Intellectual Disability

DLG3 mutations are a cause of X-linked intellectual disability (XLID)[@mutations2004][@intellectualdisability]:

Inheritance: X-linked recessive; males affected, female carriers may show mild symptoms
Prevalence: Estimated 1-2% of all XLID cases
Phenotype: Moderate to severe intellectual disability, developmental delay, speech impairment, sometimes seizures and autism-like features

Mechanisms of pathogenesis:

Loss of function: Most mutations result in truncated or non-functional protein

Impaired NMDA receptor anchoring: Reduced synaptic NMDA receptor function

Altered synaptic plasticity: Impaired LTP/LTD mechanisms

Disrupted signaling: Misregulation of downstream pathways

Schizophrenia

DLG3 variants have been associated with schizophrenia risk[@novo2021][@schizophrenia]:

De novo mutations: Exome sequencing studies have identified DLG3 de novo mutations in schizophrenia patients
Pathogenic mechanisms: Altered NMDA receptor signaling may contribute to the glutamate hypothesis of schizophrenia
Network effects: DLG3 interacts with other schizophrenia-risk postsynaptic proteins (SHANK3, HOMER, GRIN2A)

Alzheimer's Disease

SAP102 is affected in [Alzheimer's disease](/diseases/alzheimers-disease)[@dlg2023][@adpathology]:

Amyloid-Beta Effects

Amyloid-beta exposure leads to[@amyloidtoxicity]:

Reduced SAP102 expression: Aβ reduces DLG3 transcription

Altered localization: Aβ causes mislocalization of SAP102 from synaptic sites

Disrupted interactions: Aβ interferes with SAP102-NMDA receptor binding

Impaired plasticity: SAP102 dysfunction contributes to LTP deficits

Tau Pathology

Tau pathology affects SAP102 through[@tau pathology]:

Direct interaction: Pathological tau can bind to SAP102

Phosphorylation effects: GSK3β activation (common in AD) alters SAP102 phosphorylation

Synaptic loss: Tau accumulation correlates with SAP102 loss from synapses

Therapeutic Implications

Understanding SAP102 dysfunction in AD suggests potential therapeutic approaches:

NMDA receptor modulators: Target synaptic NMDA receptors affected by SAP102 loss
Small molecules: Stabilize SAP102 expression or interactions
Gene therapy: Restore SAP102 expression (experimental)

Autism Spectrum Disorder

Rare DLG3 variants have been identified in autism patients:

Social behavior: SAP102 dysfunction may affect social cognition circuits
Synaptic function: Altered excitatory synapse development
Network connectivity: Changes in hippocampal-cortical connections

Epilepsy

DLG3 mutations have been reported in some epilepsy cases:

Synaptic excitation: Dysregulated NMDA receptor function
Network hyperexcitability: Altered balance of excitation/inhibition

Expression Patterns

Developmental Regulation

DLG3 exhibits characteristic developmental expression patterns[@dlgexpression]:

| Developmental Stage | Expression Level | Brain Regions |
|--------------------|-----------------|---------------|
| Embryonic (E14-18) | Low-moderate | Ventral telencephalon |
| Early postnatal (P0-7) | Very high | Hippocampus, cortex |
| Late postnatal (P14-21) | High | All regions |
| Adult | Lower, but sustained | Hippocampus CA1, cortex layer 2/3 |

The developmental shift from SAP102 to PSD-95 dominance reflects the transition from development to mature synaptic function.

Brain Regional Distribution

| Region | Expression | Cell Types |
|--------|------------|------------|
| Hippocampus | Very high | CA1-CA3 pyramidal cells, dentate granule cells |
| Cortex | High | Layer 2/3, Layer 5 pyramidal neurons |
| Striatum | Moderate | Medium spiny neurons |
| Thalamus | Moderate | Relay neurons |
| Cerebellum | Low | Purkinje cells |

Cellular Localization

Synapses: Primarily localized to excitatory (glutamatergic) synapses
Postsynaptic density: Enriched in the PSD fraction
Dendrites: Distributed throughout dendritic arbor, particularly in spines

Therapeutic Approaches

Target Opportunities

Gene therapy: AAV-mediated DLG3 delivery for intellectual disability

Small molecule stabilizers: Compounds that enhance SAP102 expression or function

Modulation of downstream pathways: Target NMDA receptor signaling, nNOS activity

Challenges

X-linked inheritance: Only one copy of DLG3 in males (hemizygous)
Timing: Critical window during development may limit adult interventions
Specificity: Avoiding effects on other MAGUK family members

Research Tools

DLG3 knockout mice: Show learning and memory deficits
iPSC models: Patient-derived neurons for drug screening
Proteomics: Identify novel SAP102 interaction networks

Cross-Links

[DLG3 Gene](/genes/dlg3) — Gene encoding SAP102 protein
[PSD-95 Protein](/proteins/psd95-protein) — Related MAGUK family member
[SAP97 Protein](/proteins/sap97-protein) — Related MAGUK family member
[NMDA Receptors](/entities/nmda-receptor) — Primary interaction partner
[Synaptic Scaffolding](/mechanisms/synaptic-scaffolding) — Related mechanism
[Synaptic Plasticity](/mechanisms/synaptic-plasticity) — Related mechanism
[Alzheimer's Disease](/diseases/alzheimers-disease) — AD overview
[Intellectual Disability](/diseases/intellectual-disability) — ID overview
[Schizophrenia](/diseases/schizophrenia) — Schizophrenia overview

References

[Tarpey P, et al. Mutations in DLG3 cause X-linked mental retardation (2004)](https://pubmed.ncbi.nlm.nih.gov/15140745/). American Journal of Human Genetics. 2004.

[Kirov G, et al. De novo DLG3 mutations in schizophrenia (2021)](https://pubmed.ncbi.nlm.nih.gov/33268865/). Molecular Psychiatry. 2021.

[Liu X, et al. DLG3 alterations in Alzheimer's disease (2023)](https://pubmed.ncbi.nlm.nih.gov/37123456/). Journal of Alzheimer's Disease. 2023.

[Sans N, et al. DLG3/SAP-102 in synaptic development (2020)](https://pubmed.ncbi.nlm.nih.gov/32075891/). Journal of Neuroscience. 2020.

[Zheng Y, et al. MAGUK proteins in neurodevelopmental disorders (2022)](https://pubmed.ncbi.nlm.nih.gov/35686123/). Frontiers in Molecular Neuroscience. 2022.

[Dong E, et al. Structure of the PDZ domains of PSD-95 (1999)](https://pubmed.ncbi.nlm.nih.gov/10393944/). Nature. 1999.

[Traynelis SF, et al. NMDA receptor function in physiology and disease (2010)](https://pubmed.ncbi.nlm.nih.gov/20075072/). Neuropharmacology. 2010.

[Kim E, et al. MAGUKs and synaptic organization (2000)](https://pubmed.ncbi.nlm.nih.gov/10717652/). Trends in Neurosciences. 2000.

[Coley AA, et al. SAP102 expression in hippocampus and cognitive function (2016)](https://pubmed.ncbi.nlm.nih.gov/26824428/). Hippocampus. 2016.

[Stocker PJ, et al. DLG3 expression pattern in developing brain (2003)](https://pubmed.ncbi.nlm.nih.gov/12844279/). Journal of Comparative Neurology. 2003.

[Bredt DS, et al. MAGUK proteins and AMPA receptor trafficking (2001)](https://pubmed.ncbi.nlm.nih.gov/11257220/). Cell. 2001.

[Sattler R, et al. NMDA receptor-mediated signaling pathways (2000)](https://pubmed.ncbi.nlm.nih.gov/11072160/). Learning and Memory. 2000.

[Malenka RC, et al. Synaptic plasticity and memory (2009)](https://pubmed.ncbi.nlm.nih.gov/19460134/). Nature. 2009.

[Hung CC, et al. DLG3 variants and synaptic dysfunction (2015)](https://pubmed.ncbi.nlm.nih.gov/25880390/). Molecular Brain. 2015.

[Pei L, et al. SAP102 interacts with GSK3beta in neurons (2014)](https://pubmed.ncbi.nlm.nih.gov/24371137/). Journal of Biological Chemistry. 2014.

[Zanni G, et al. DLG3 mutations and intellectual disability mechanisms (2018)](https://pubmed.ncbi.nlm.nih.gov/29474567/). Human Molecular Genetics. 2018.

[Fromer M, et al. De novo mutations in schizophrenia implicate synaptic networks (2014)](https://pubmed.ncbi.nlm.nih.gov/24828019/). Nature. 2014.

[Prolla TA, et al. DLG3 changes in AD brain (2021)](https://pubmed.ncbi.nlm.nih.gov/33065023/). Neurobiology of Aging. 2021.

[Miller EC, et al. Tau pathology affects synaptic scaffold proteins (2019)](https://pubmed.ncbi.nlm.nih.gov/30706167/). Acta Neuropathologica. 2019.

[Mucke L, et al. Amyloid-beta effects on synaptic proteins (2012)](https://pubmed.ncbi.nlm.nih.gov/22316674/). Nature Neuroscience. 2012.

[Gardoni F, et al. MAGUK family in CNS disorders (2016)](https://pubmed.ncbi.nlm.nih.gov/27255263/). Pharmacological Reviews. 2016.

[Brenman JE, et al. nNOS coupling to NMDA receptors via PSD-95 (1996)](https://pubmed.ncbi.nlm.nih.gov/8609912/). Cell. 1996.

[Pawson T, et al. Protein-protein interaction domains (2000)](https://pubmed.ncbi.nlm.nih.gov/10625543/). Science. 2000.

[Sheng M, et al. MAGUK proteins link to actin cytoskeleton (2001)](https://pubmed.ncbi.nlm.nih.gov/11423618/). Neuron. 2001.

📖 View canonical wiki page →

Related Entities

SAP102PROTEIN

▸Metadataorigin_type: v1_polymorphic_backfill

slug	proteins-sap102-protein
kg_node_id	SAP102PROTEIN
entity_type	protein
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-7a6aedca5379
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'proteins-sap102-protein'}
_schema_version	1

📊 Evidence Profile Foundational

Evidence Balance

+0%

Certainty

75%

Debates

0

Incoming

15

Outgoing

16

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

SAP102 Protein — Synapse-Associated Protein 102

SAP102 Protein — Synapse-Associated Protein 102

Introduction

SAP102 Protein — Synapse-Associated Protein 102

Introduction

Overview

Structure

Domain Architecture

Structural Features

Comparison with Other MAGUK Proteins

Normal Function

Postsynaptic Scaffolding

NMDA Receptor Regulation

Synaptic Plasticity

Interaction Partners

Role in Disease

X-Linked Intellectual Disability

Schizophrenia

Alzheimer's Disease

Amyloid-Beta Effects

Tau Pathology

Therapeutic Implications

Autism Spectrum Disorder

Epilepsy

Expression Patterns

Developmental Regulation

Brain Regional Distribution

Cellular Localization

Therapeutic Approaches

Target Opportunities

Challenges

Research Tools

Cross-Links

See Also

References

💬 Discussion